日本特发性肺纤维化疾病严重度分期系统的修订与验证
修订版J-system的C-statistic为0.677,高于改良GAP系统(0.652)和现行J-system(0.659),且多因素分析显示修订版J-system(P=0.0038)和改良GAP系统(P=0.0029)均为独立预后因素。结论认为修订版J-system能提供更好的死亡预测。
要点
- 修订版J-system对IPF死亡的判别能力优于现行J-system和改良GAP系统。
- 修订版J-system和改良GAP系统均为IPF独立的预后因素。
- 现行J-system对I、II期患者的预后区分能力不足,修订版旨在改善。
核心结论
- 修订版J-system能比现行J-system提供更好的死亡预测。
- 修订版J-system和改良GAP系统均为IPF预后和临床管理的独立、有价值的工具。
研究设计与样本
- 采用Cox比例风险模型比较修订版J-system、现行J-system和改良GAP系统对死亡率的预测能力。
主要发现
- 单变量模型显示现行J-system、修订版J-system和改良GAP系统均为显著预后因素。
- 修订版J-system的C-statistic为0.677,改良GAP系统为0.652,现行J-system为0.659。
- bootstrap样本的C-statistic分别为修订版J-system 0.665(95%CI: 0.621-0.705)、改良GAP系统0.645(95%CI: 0.600-0.686)、现行J-system 0.659(95%CI: 0.616-0.700)。
- 多因素分析显示修订版J-system(P=0.0038)和改良GAP系统(P=0.0029)为独立预后因素。
临床怎么用
- 修订版J-system可用于IPF患者的预后评估和临床管理决策。
- 改良GAP系统同样可作为IPF预后的独立工具。
局限性
- 研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: In Japan, the classification of disease severity of idiopathic pulmonary fibrosis (IPF) (J-system) has been used in making decisions on medical care subsidies. The present J-system consists of arterial partial pressure of oxygen (PaO2 ) and exercise desaturation in stages of I-IV. It provides a good prognostic classification in stages III and IV, but not in stages I and II. Therefore, we propose a revised system to improve discriminative ability in stages I and II. METHODS: We compared the revised J-system with the present J-system using Cox proportional hazards model to predict mortality rate. We also evaluated the recently proposed GAP (Gender, Age and Physiology) system in comparison to both J-systems. RESULTS: Two-hundred and fifteen IPF patients were studied retrospectively. A univariate model showed that the present and revised J-systems and a modified GAP system were all significant prognostic factors. The C-statistic for discriminating prognosis was higher in the revised J-system than the modified GAP system and the present J-system (0.677, 0.652 and 0.659, respectively). The C-statistics of these models produced from the 10 000 bootstrap samples were similar to those of the original models, suggesting good internal validation (0.665 (95% CI: 0.621-0.705), 0.645 (0.600-0.686) and 0.659 (0.616-0.700), respectively). Multivariate analysis revealed that the revised J-system (P = 0.0038) and the modified GAP system (P = 0.0029) were independent prognostic factors. CONCLUSION: The revised J-system can provide a better mortality prediction than the present one. Both the revised J-system and the modified GAP system are independent and valuable tools for prognostication and clinical management for IPF.
引用
- Kondoh Y, Taniguchi H, Kataoka K, et al. Disease severity staging system for idiopathic pulmonary fibrosis in Japan. Respirology. 2017. PMID: 28787101. doi:10.1111/resp.13138
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。